Exchange: PNK Industry: Packaged Foods
-9.49% $0.510
America/New_York / 3 mai 2024 @ 14:41
FUNDAMENTALS | |
---|---|
MarketCap: | 33.43 mill |
EPS: | -0.0200 |
P/E: | -25.50 |
Earnings Date: | May 10, 2023 |
SharesOutstanding: | 65.54 mill |
Avg Daily Volume: | 0.0007 mill |
RATING 2024-05-03 |
---|
C |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Strong Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | n/a | |||||
Gr.Profit | n/a | |||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -25.50 | sector: PE -11.58 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -25.50 | industry: PE -46.44 |
DISCOUNTED CASH FLOW VALUE |
---|
$-0.0696 (-113.64%) $-0.580 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
$ 0.487 - 0.533 ( +/- 4.51%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2015-03-30 | Xin Sun | Buy | 3 000 000 | Common Stock, par value $0.0001 |
2013-08-21 | Xin Sun | Sell | 15 495 900 | Common Stock, par value $0.0001 |
2009-04-07 | Xin Sun | Sell | 28 200 000 | Common Stock |
2008-12-31 | Xin Sun | Buy | 60 000 000 | Common stock, par value $.0001 per share |
2007-09-10 | Xin Sun | Sell | 0 | Common Stock, $0.0001 par value |
INSIDER POWER |
---|
0.00 |
Last 13 transactions |
Buy: 63 000 000 | Sell: 43 695 900 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $0.510 (-9.49% ) |
Volume | 0.0014 mill |
Avg. Vol. | 0.0007 mill |
% of Avg. Vol | 195.51 % |
Signal 1: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. It offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, and hemp frozen age nourishing creams. The company also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, it offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, the company manufactures and sells various types of medical drugs. It primarily sells its products through sales agents. China Health Industries Holdings, Inc. is based in Harbin City, the People's Republic of China.